R.M. Davis Inc’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.4M | Sell |
122,380
-612
| -0.5% | -$294K | 0.97% | 30 |
|
|
2026
Q1 | $60.5M | Sell |
122,992
-1,139
| -0.9% | -$618K | 1.07% | 27 |
|
|
2025
Q4 | $71.9M | Sell |
124,131
-1,748
| -1% | -$988K | 1.24% | 20 |
|
|
2025
Q3 | $61.1M | Sell |
125,879
-2,494
| -2% | -$1.16M | 1.07% | 27 |
|
|
2025
Q2 | $52.1M | Sell |
128,373
-1,322
| -1% | -$553K | 0.97% | 32 |
|
|
2025
Q1 | $64.5M | Sell |
129,695
-1,380
| -1% | -$747K | 1.29% | 23 |
|
|
2024
Q4 | $68.2M | Sell |
131,075
-818
| -0.6% | -$450K | 1.33% | 21 |
|
|
2024
Q3 | $81.6M | Buy |
131,893
+4,225
| +3% | +$2.5M | 1.58% | 16 |
|
|
2024
Q2 | $70.6M | Sell |
127,668
-2,688
| -2% | -$1.54M | 1.43% | 19 |
|
|
2024
Q1 | $75.8M | Sell |
130,356
-606
| -0.5% | -$340K | 1.59% | 16 |
|
|
2023
Q4 | $69.5M | Sell |
130,962
-7,341
| -5% | -$3.55M | 1.6% | 17 |
|
|
2023
Q3 | $70M | Sell |
138,303
-3,678
| -3% | -$1.96M | 1.76% | 12 |
|
|
2023
Q2 | $74.1M | Sell |
141,981
-1,772
| -1% | -$956K | 1.78% | 10 |
|
|
2023
Q1 | $82.9M | Sell |
143,753
-886
| -0.6% | -$499K | 2.11% | 9 |
|
|
2022
Q4 | $79.7M | Buy |
144,639
+67
| +0% | +$35.5K | 2.15% | 8 |
|
|
2022
Q3 | $73.3M | Sell |
144,572
-155
| -0.1% | -$86.7K | 2.13% | 8 |
|
|
2022
Q2 | $78.6M | Buy |
144,727
+763
| +0.5% | +$420K | 2.19% | 5 |
|
|
2022
Q1 | $85M | Buy |
143,964
+194
| +0.1% | +$111K | 2.02% | 8 |
|
|
2021
Q4 | $95.9M | Sell |
143,770
-711
| -0.5% | -$444K | 2.14% | 6 |
|
|
2021
Q3 | $82.5M | Buy |
144,481
+135
| +0.1% | +$74.1K | 2.05% | 8 |
|
|
2021
Q2 | $72.8M | Buy |
144,346
+440
| +0.3% | +$208K | 1.83% | 10 |
|
|
2021
Q1 | $65.7M | Sell |
143,906
-1,945
| -1% | -$928K | 1.8% | 10 |
|
|
2020
Q4 | $67.9M | Sell |
145,851
-1,683
| -1% | -$789K | 1.95% | 10 |
|
|
2020
Q3 | $65.1M | Sell |
147,534
-3,564
| -2% | -$1.47M | 2.13% | 7 |
|
|
2020
Q2 | $54.7M | Sell |
151,098
-2,310
| -2% | -$774K | 1.95% | 9 |
|
|
2020
Q1 | $43.5M | Sell |
153,408
-1,577
| -1% | -$497K | 1.81% | 11 |
|
|
2019
Q4 | $50.4M | Sell |
154,985
-2,256
| -1% | -$684K | 1.65% | 14 |
|
|
2019
Q3 | $45.8M | Sell |
157,241
-1,259
| -0.8% | -$361K | 1.61% | 15 |
|
|
2019
Q2 | $46.5M | Sell |
158,500
-1,712
| -1% | -$472K | 1.66% | 16 |
|
|
2019
Q1 | $43.9M | Sell |
160,212
-1,046
| -0.6% | -$260K | 1.63% | 19 |
|
|
2018
Q4 | $36.1M | Sell |
161,258
-490
| -0.3% | -$115K | 1.48% | 24 |
|
|
2018
Q3 | $39.5M | Sell |
161,748
-1,219
| -0.7% | -$280K | 1.43% | 28 |
|
|
2018
Q2 | $33.8M | Buy |
162,967
+2,940
| +2% | +$624K | 1.31% | 31 |
|
|
2018
Q1 | $33M | Buy |
160,027
+2,811
| +2% | +$590K | 1.32% | 32 |
|
|
2017
Q4 | $29.9M | Buy |
157,216
+4,427
| +3% | +$848K | 1.17% | 41 |
|
|
2017
Q3 | $28.9M | Buy |
152,789
+1,466
| +1% | +$266K | 1.19% | 39 |
|
|
2017
Q2 | $26.4M | Buy |
151,323
+3,242
| +2% | +$545K | 1.12% | 40 |
|
|
2017
Q1 | $22.7M | Buy |
148,081
+15,535
| +12% | +$2.37M | 1.03% | 43 |
|
|
2016
Q4 | $18.7M | Buy |
132,546
+62,418
| +89% | +$9.2M | 0.89% | 48 |
|
|
2016
Q3 | $11.2M | Buy |
70,128
+23,265
| +50% | +$3.59M | 0.54% | 67 |
|
|
2016
Q2 | $6.92M | Buy |
46,863
+29,705
| +173% | +$4.38M | 0.34% | 77 |
|
|
2016
Q1 | $2.43M | Buy |
17,158
+14,111
| +463% | +$1.89M | 0.12% | 90 |
|
|
2015
Q4 | $432K | Buy |
3,047
+454
| +18% | +$60.6K | 0.02% | 154 |
|
|
2015
Q3 | $317K | Buy |
+2,593
| New | +$338K | 0.02% | 166 |
|
Other funds holding TMO
R.M. Davis Inc's TMO Position: Q2 2026 in Review
R.M. Davis Inc reduced its Thermo Fisher Scientific (TMO) stake by 0.5% in Q2 2026, selling an estimated $294K and leaving 122,380 shares worth $61.4M. The position accounts for 0.97% of the portfolio, ranked #30.
R.M. Davis Inc first reported a position in TMO in Q3 2015 and has held it in 44 quarters since. The position peaked at $95.9M in Q4 2021. 2,603 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- R.M. Davis Inc held 122,380 shares of Thermo Fisher Scientific worth $61.4M as of Q2 2026.
- R.M. Davis Inc sold 612 Thermo Fisher Scientific shares in Q2 2026, an estimated $294K.
- Thermo Fisher Scientific made up 0.97% of R.M. Davis Inc's portfolio in Q2 2026, its #30 holding.
- R.M. Davis Inc first reported a position in Thermo Fisher Scientific in Q3 2015 and has held it in 44 quarters since.
- R.M. Davis Inc's Thermo Fisher Scientific position peaked at $95.9M in Q4 2021.
- 2,603 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on R.M. Davis Inc's 13F filing for Q2 2026, filed 14 Aug 2026.